Glenmark Pharmaceuticals Inc.,Usa

Name: Glenmark Pharmaceuticals Inc.,Usa | See Full Importer History | ImportGenius
Creator: ImportGenius
License: https://creativecommons.org/licenses/by-nc-nd/4.0/

US Customs records for Glenmark Pharmaceuticals Inc.,Usa in Penn Allentown. See their past imports and exports, including shipments from Glenmark Pharmaceuticals Ltd, a supplier based in India.

Call ImportGenius Sales

Join ImportGenius to see the import/export activity of every company in the United States. Track your competitors, get freight forwarding leads, enforce exclusivity agreements, learn more about your overseas factories, and much more. Instant signup.

Get United States data for $229

Total Shipments

3,099

Trading Partners

Top Partner

GLENMARK PHARMACEUTICALS LIMITED

Ports

Top Port

Nhava Sheva

Contact Info

Glenmark Pharmaceuticals Inc.,Usa

749 South Pa Route 100 Suite A Penn Allentown Nj 18106 Us

Glenmark Pharmaceuticals Inc.,Usa Records

Get a complete importer history

Updated: 2026-07-21

Total shipments from 2006-11-01 to 2026-07-21

Precise data and chart data points are only available to paid subscribers

Importer Shipments

Top Trading Partners

Legend

Top Ports

Legend

Nhava Sheva
Salalah
Mundra
Colombo
Bremerhaven

Total shipments from 2006-11-01 to 2026-07-21

Precise data and chart data points are only available to paid subscribers

Importer Shipments

#	Bill of Lading	Product	Importer	Supplier	Arrival Date	Country of Origin	Gross Weight KGS	Quantity
1	MAEU271902481	47 PACKAGES 2130 CARTONS PHARMACEUTICALS AS UNDER ATOMOXETINE CAP 25MG 30 NDC CODE68462026730 FDA PRODUCT CODE NO. 64 UCA 99 H. T. S NO. 3004.90.92.90 ANDA NO. 079019 THERAPEUTICEUSE ATOMOXETINE IS USED TO TREAT ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) AS PARTOF A TOTAL TREATMENT PLAN INCLUDING PSYCHOLO, GICAL SOCIAL AND OTHER TREATMENTS OMEPRAZOLEDR CAP 20MG 1000 NDC CODE68462039610 FDA PRO DUCT CODE NO.62KCF10 HTS NO.3004.90.9255 ANDANO.91672 THERAPEUTICE USE TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE ONDANSETRON ODT 8MG 10UD NDC CODE68462015811 FDA PRODUCT CODE NO.61 T C A 26 H. T. S NO. 3004.90.92.4 0 ANDA NO.78152 THERAPEUTICE USEANTI EMETICMUPIROCIN OINT 2 22GM NDC CODE68462018022 FDAPRODUCT CODE NO. 61 G J J 81 H. T. S NO. 300 4.90.92.45 ANDA NO. 90480 THERAPEUTICE USE ANTIBACTERIAL CLINDAMYCINBPO GEL JAR 15 50GM NDC CODE68462048627 FDA PRODUCT CODE NO. 56 JD J 31 H. T. S NO. 3004.49.00.50 ANDA NO. 20 9252 ANTIBIOTIC THAT STOPS THE GROWTH OF ACNECAUSING BACTERIA AS WELL AS REDUCE OIL PRODUCTION IN THE SKIN HELPING KEEP PORES OPEN OMEPRAZOLE DR CAP 20MG 1000 NDC CODE68462039610 FDA PRODUCT CODE NO.62KCF10 HTS NO.3004.90.9255 ANDA NO.91672 THERAPEUTICE USE TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE ATOMOXETINE CAP 25MG 30 NDC CODE68462026730 FDA PRODUCT CODE NO. 64 UCA 99 H. T. S NO. 3004.90.92.90 ANDA NO. 079019 THERAPEUTICE USE ATOMOXETINE IS USED TO TREAT ATTENTIONDEFICIT HYPERACTIVITY DISORDER (ADHD) AS PART OF A TOTAL TREATMENT PLAN INCLUDING PSYCHOLOGICAL SOCIAL AND OTHER TREATMENTS COMMERCIAL CUSTOM INVOICE NO. F22752001197 DT. 15.06.2026 F22752001198 DT. 15.06.2026 F22752001191 DT. 15.06.2026 F22752001199 DT. 15.06.2026 F22752001210DT. 16.06.2026 F22752001212 DT. 16.06.2026 SBILL NO 4192431 DT 16JUN2026 SBILL NO 4192432DT 16JUN2026 SBILL NO 4192413 DT 16JUN2026 S BILL NO 4192435 DT 16JUN2026 SBILL NO 4210368DT 16JUN2026 SBILL NO 4210550 DT 16JUN2026 GROSS WT.9446.590 KGS NET WT.7583.310 KGS 03DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE XXXXXXXXXXXXXXXXXXXXXXXXX	GLENMARK PHARMACEUTICALS INC. USA	GLENMARK PHARMACEUTICALS LIMITED	2026-07-21	India	9466 Kgs	12 PKG
2	MAEU271902478	42 PACKAGES 2641 CARTONS PHARMACEUTICALS AS UNDER ONDANSETRON ODT 4MG 30UD NDC CODE68462015713 FDA PRODUCT CODE NO61 T C A 26 H. T. S NO. 3004.90.92.40 ANDA NO.78152 THERAPEUTICE USEANTI EMETIC ESTRADIOL VAG INSERTS 10MCG 8NDC CODE68462071171 FDA PRODUCT CODE NO. 64 G C A 28 H. T. S NO. 3006.60.00.00 ANDA NO.21, 0264 THERAPEUTICE USETHE TREATMENT OF ATROPICVAGINITIS DUE TO MENOPAUSE. HAILEY 24 FE TA B 1MG20MCG75MG 84 NDC CODE68462073129 FDA PRODUCT CODE NO. 65 J D A 25 H. T. S NO. 3006.60.00.00 ANDA NO. 204847 THERAPEUTICE USE CONTRACEPTION TO PREVENT PREGNANCY COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT. 13.06.2026F22752001170 DT. 13.06.2026 F22752001172 DT.13.06.2026 SBILL NO 4132796 DT 13JUN2026 SBI LL NO 4132804 DT 13JUN2026 SBILL NO 4132795 DT 13JUN2026 GROSS WT.6429.380 KGS NET WT.4596.940 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE XXXXXXXXXXXX	GLENMARK PHARMACEUTICALS INC. USA	GLENMARK PHARMACEUTICALS LIMITED	2026-07-21	India	6443 Kgs	42 PKG
3	MAEU271902388	40 PACKAGES 2246 CARTONS PHARMACEUTICALS AS UNDER ONDANSETRON ODT 4MG 30UD NDC CODE68462015713 FDA PRODUCT CODE NO61 T C A 26 H. T. S NO. 3004.90.92.40 ANDA NO.78152 THERAPEUTICE USEANTI EMETIC NORETH ACEEE TAB 10.02MG 63 NDC CODE68462013281 FDA PRODUCT CODE NO.65 J CA 25 H. T. S NO. 3006.60.00.00 ANDA NO.20696, 9 THERAPEUTICE USE SECONDARY AMENORRHEAENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT. 15.06.2026 F22752001187 DT. 15.06.2026 SBILL NO4162283 DT 15JUN2026 SBILL NO4162288 DT 15JUN2026 GROSS WT.5674.470 KGS NET WT.4019.290 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREESTO 25 DEGREES NOTIFY PARTY2 XXXXXXXXXXXXXXXXXHWAH 07430 USA	GLENMARK PHARMACEUTICALS INC. USA	GLENMARK PHARMACEUTICALS LIMITED	2026-07-21	India	5686 Kgs	40 PKG
4	YASVBOM0081565	PHARMACEUTICAL PRODUCT	GLENMARK PHARMACEUTICALS INC., USA	GLENMARK PHARMACEUTICALS LIMITED	2026-07-18	India	6596 Kgs	40 PKG
5	YASVBOM0081564	PHARMACEUTICAL PRODUCT	GLENMARK PHARMACEUTICALS INC., USA	GLENMARK PHARMACEUTICALS LIMITED	2026-07-18	India	11441 Kgs	40 PKG
6	YASVBOM0081563	PHARMACEUTICAL PRODUCT	GLENMARK PHARMACEUTICALS INC., USA	GLENMARK PHARMACEUTICALS LIMITED	2026-07-18	India	11234 Kgs	40 PKG
7	MAEU271557383	13 PACKAGES 966 CARTONS PHARMACEUTICALS AS UNDER LACOSAMIDE TAB 50MG 60 NDC CODE68462067860 FDA PRODUCT CODE NO. 61 M C A 47 H. T. S NO. 3004.90.9230 ANDA NO. 205006 THERAPEUTICE USE LACOSAMIDE TABLETS ARE INDICATED AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PARTIALONSET SEIZURES IN PATIENTS WITH EPILEPSY AGED 17, YEARS AND OLDER. LACOSAMIDE TAB 100MG 60 NDCCODE68462067960 FDA PRODUCT CODE NO. 61 M C A 47 H. T. S NO. 3004.90.9230 ANDA NO. 205006THERAPEUTICE USE LACOSAMIDE TABLETS ARE INDI CATED AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PARTIALONSET SEIZURES IN PATIENTS WITH EPILEPSY AGED 17 YEARS AND OLDER. LACOSAMIDE TAB 200MG 60 NDC CODE68462068160 FDA PRODUCT CODE NO. 61 M C A 47 H. T. S NO. 3004.90.9230 ANDA NO. 205006 THERAPEUTICE USE LACOSAMIDE TABLETS ARE INDICATED AS ADJUNCTIVE THERAPY IN THE TREATMENT OF PARTIALONSET SEIZURES IN PATIENTS WITH EPILEPSY AGED 17 YEARS AND OLDER. COMMERCIAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT. 08.06.2026 GROSS WT.2616.502 KGS NET WT.779.162 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 DEGREES SBILL NO 3985826 DT09JUN26 NOTIFY PARTY2 XXXXXXXXXXXXXXXXXXXXXXXXX430 USA	GLENMARK PHARMACEUTICALS INC. USA	GLENMARK PHARMACEUTICALS LIMITED	2026-07-14	India	2622 Kgs	13 PKG
8	MAEU271145494	44 PACKAGES 2120 CARTONS PHARMACEUTICALS AS UNDER ZOLMITRIPTAN TAB 5 MG 3UD NDC CODE68462049833 FDA PRODUCT CODE NO. 63OCA08 H. T. S NO. 3004.90.92.28 ANDA NO. 201779 THERAPEUTICEUSE ANALGESIC HUMAN RXSINGLE INGREDIENT PROM PT RELEASE TABLETS ZOLMITRIPTAN (ANALGESIC) OLMESARTAN MEDOX TAB 40MG 90 NDC CODE68462043, 890 FDA PRODUCT CODE NO. 62 CCA 68 H. T. S NO. 3004.90.9220 ANDA NO. 203281 TREATMENT OF HYPERTENSION ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS TO LOWER BLOOD PRESSURE ONDANSETRON ODT 8MG 30UD NDC CODE68462015813 FDA PRODUCT CODE.61 T C A 26 H. T. S NO. 3004.90.92.40ANDA NO.78152 THERAPEUTICE USEANTI EMETIC O LMESARTAN MEDOX TAB 40MG 90 NDC CODE68462043890 FDA PRODUCT CODE NO. 62 CCA 68 H. T. S NO.3004.90.9220 ANDA NO. 203281 TREATMENT OF HY PERTENSION ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS TO LOWER BLOOD PRESSURE COMMERCIALCUSTOM INVOICE NO. XXXXXXXXXXXX DT. 30.05.2 026 F22752000916 DT. 30.05.2026 F22752000918 DT. 30.05.2026 SBILL NO 3752127 DT 01JUN2026 SBILL NO 3752122 DT 01JUN2026 SBILL NO 3754848 DT 01JUN2026 GROSS WT.7633.533 KGS NET WT.5528.065 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE XXXXXXXXX	GLENMARK PHARMACEUTICALS INC. USA	GLENMARK PHARMACEUTICALS LIMITED	2026-07-07	India	7650 Kgs	44 PKG
9	MAEU271575050	PART OF FCL 9 PACKAGES 526 CARTONS PHARMACEUTICALS AS UNDER ROPIVACAINE HYDROCHLORIDE INJECTIONUSP 150MG30ML(5MGML) NDC CODE 68462079484 HTS 3004.90.9244 FDA CODE 65 Q D K 64 ANDA219883 02 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 DEGREES COMMERCIAL CUSTOM INVOICE, NO. XXXXXXXXXXXXX DT. 26.05.2026 SBILL NO 36 67260 DT 29MAY2026 GROSS WT.4195.910 KGS NETWT.1972.500 KGS NOTIFY PARTY2 XXXXXXXXXXXXXXER CODE 68462	GLENMARK PHARMACEUTICALS INC. USA	ANTHEA PHARMA PRIVATE LIMITED	2026-07-07	India	4205 Kgs	9 PKG
10	MAEU271386888	PART OF FCL 10 PACKAGES 917 CARTONS PHARMACEUTICALS AS UNDER BUMETANIDE INJECTION USP 2.5MG10ML (0.25MGML) NDC NO. 6846247054 FDA PRODUCT CODE 64 B C K 09 ANDA NO. 216434 H. T. S NO. 3004.90.9259 COMMERCIAL CUSTOM INVOICE NO. M72717000142 DT. 27.05.2026 SBILL NO3634184 DT 28MAY2026 GROSS WT. 4920.532 KGS, NET WT.4244.429 KGS 02 DATA LOGGERS HUMIDIT Y65 SET TEMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 DEGREES NOTIFY PARTY2GLENMARK PHARMACEUTICALS INC. USA 749 SOUTH PA ROUTE 100 SUITE A PENNSYLVANIA ALLENTOWN USA 18106 LABELER CODE 68462	GLENMARK PHARMACEUTICALS INC. USA	GLAND PHARMA LIMITED	2026-07-07	India	4931 Kgs	10 PKG

#	Importer	Last Address	Most Recent

#	Supplier	Last Address	Most Recent	No. of Containers	Gross Weight KGS
1	GLENMARK PHARMACEUTICALS LIMITED	India	2026-07-21	2946	17383456
2	GLENMARK GENERICS LTD	India	2019-05-01	14	78248
3	ENCUBE ETHICALS PVT LTD	India	2018-12-24	12	97265
4	ANTHEA PHARMA PRIVATE LIMITED	Oman	2026-07-07	11	61944
5	N/A	India	2018-09-20	10	67202

More data available to paid subscribers

Sample Shipment From Glenmark Pharmaceuticals Inc.,Usa

Bill of Lading MAEU271902481

Arrival Date: 2026-07-21

Container Number: MNBU4494651

Cargo #1
Description 47 PACKAGES 2130 CARTONS PHARMACEUTICALS AS U NDER ATOMOXETINE CAP 25MG 30 NDC CODE6846202 6730 FDA PRODUCT CODE NO. 64 UCA 99 H. T. S N O. 3004.90.92.90 ANDA NO. 079019 THERAPEUTICE USE ATOMOXETINE IS USED TO TREAT ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) AS PART OF A TOTAL TREATMENT PLAN INCLUDING PSYCHOLO GICAL SOCIAL AND OTHER TREATMENTS OMEPRAZOLE DR CAP 20MG 1000 NDC CODE68462039610 FDA PRO DUCT CODE NO.62KCF10 HTS NO.3004.90.9255 ANDA NO.91672 THERAPEUTICE USE TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE ONDANSETRON ODT 8MG 10UD NDC CODE68462015811 FDA PRODUCT CODE NO.61 T C A 26 H. T. S NO. 3004.90.92.4 0 ANDA NO.78152 THERAPEUTICE USEANTI EMETIC MUPIROCIN OINT 2 22GM NDC CODE68462018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T. S NO. 300 4.90.92.45 ANDA NO. 90480 THERAPEUTICE USE A NTIBACTERIAL CLINDAMYCINBPO GEL JAR 15 50GM NDC CODE68462048627 FDA PRODUCT CODE NO. 56 J D J 31 H. T. S NO. 3004.49.00.50 ANDA NO. 20 9252 ANTIBIOTIC THAT STOPS THE GROWTH OF ACNE CAUSING BACTERIA AS WELL AS REDUCE OIL PRODUC TION IN THE SKIN HELPING KEEP PORES OPEN OME PRAZOLE DR CAP 20MG 1000 NDC CODE68462039610 FDA PRODUCT CODE NO.62KCF10 HTS NO.3004.90.92 55 ANDA NO.91672 THERAPEUTICE USE TREATMENT O F TREAT GASTROESOPHAGEAL REFLUX DISEASE ATOM OXETINE CAP 25MG 30 NDC CODE68462026730 FDA P RODUCT CODE NO. 64 UCA 99 H. T. S NO. 3004.90 .92.90 ANDA NO. 079019 THERAPEUTICE USE ATO MOXETINE IS USED TO TREAT ATTENTIONDEFICIT HY PERACTIVITY DISORDER (ADHD) AS PART OF A TOTA L TREATMENT PLAN INCLUDING PSYCHOLOGICAL SOCI AL AND OTHER TREATMENTS COMMERCIAL CUSTOM I NVOICE NO. F22752001197 DT. 15.06.2026 F22752 001198 DT. 15.06.2026 F22752001191 DT. 15.06. 2026 F22752001199 DT. 15.06.2026 F22752001210 DT. 16.06.2026 F22752001212 DT. 16.06.2026 S BILL NO 4192431 DT 16JUN2026 SBILL NO 4192432 DT 16JUN2026 SBILL NO 4192413 DT 16JUN2026 S BILL NO 4192435 DT 16JUN2026 SBILL NO 4210368 DT 16JUN2026 SBILL NO 4210550 DT 16JUN2026 GROSS WT.9446.590 KGS NET WT.7583.310 KGS 03 DATA LOGGERS HUMIDITY65 SET TEMPERATURE 18 DEGREES TEMPERATURE XXXXXXXXXXXXXXXXXXXXXXXXX
Keywords pharmaceuticals	HS-Code DATA UNAVAILABLE	Piece Count 47

Length 480	Height 108
Width 96	Load Status Loaded
Seal IN3579971, KLIK21347346	Equipment Description R1
Type 40 Foot Integral Reefer Container, Mechanically refrigerated and heated	Type of Service Container Yard
Container Type 40 Foot Integral Reefer Container, Mechanically refrigerated and heated	Marks & Numbers MANUFACTURE D FOR GLENMARK PHARMACEUTICAL S I NC. USA 749 SOUTH PA ROUTE 100 SUITE A ALLENT OWN

Carrier MAERSK LINE	Carrier Code MAEU
Carrier Address 2 GIRALDA FARMS, MADISON AVE.	Carrier Contact Number DATA UNAVAILABLE
Ship Registered In DATA UNAVAILABLE	Foreign Port JAWAHARLAL NEHRU
Voyage Number 624W	Country of Origin INDIA
Vessel Name MAERSK SEBAROK	U.S. Port DATA UNAVAILABLE
Master Bill of Lading MAEU271902481	Weight (LB/KG) 20829.59063964844 / 9446.5263671875
Quantity 12 PKG	Container Count 1
Place of Receipt JAWAHARLAL NEHRU	Distribution Port DATA UNAVAILABLE
House-v-Master DATA UNAVAILABLE	Measurement DATA UNAVAILABLE
In-Bond Entry-Type DATA UNAVAILABLE	Bill Type Code Regular Bill